Dr. Robert Califf,  former commissioner of the Food and Drug Administration, said Wednesday the current clinical trial system isn’t working and outlined his vision for a future system based on high-quality evidence and widespread data sharing.

“Beyond early phase intensive mechanistic exploratory trials, I think the clinical trials enterprise has gone awry,” he said, speaking at a conference on clinical trials hosted by the New York Academy of Sciences, “It’s become unnecessarily expensive, cumbersome, arcane, and it’s causing, I think, a search for alternatives partly out of desperation, because the way it’s being done now isn’t answering the questions people are most concerned about.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy